| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bronchopulmonary Dysplasia | 16 | 2023 | 161 | 7.330 |
Why?
|
| Hyperoxia | 18 | 2022 | 133 | 6.990 |
Why?
|
| Receptors, Aryl Hydrocarbon | 10 | 2022 | 85 | 5.030 |
Why?
|
| Lung | 21 | 2023 | 3151 | 3.860 |
Why?
|
| Hypertension, Pulmonary | 9 | 2023 | 462 | 3.820 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 6 | 2022 | 622 | 2.700 |
Why?
|
| Adrenomedullin | 4 | 2021 | 104 | 2.440 |
Why?
|
| Omeprazole | 5 | 2016 | 92 | 2.370 |
Why?
|
| Endothelial Cells | 7 | 2020 | 1048 | 1.770 |
Why?
|
| Lipopolysaccharides | 4 | 2022 | 558 | 1.400 |
Why?
|
| Cytochrome P-450 CYP1A1 | 5 | 2017 | 102 | 1.340 |
Why?
|
| Pulmonary Alveoli | 5 | 2018 | 208 | 1.340 |
Why?
|
| Acute Lung Injury | 3 | 2022 | 92 | 1.260 |
Why?
|
| NAD(P)H Dehydrogenase (Quinone) | 2 | 2017 | 60 | 1.110 |
Why?
|
| Animals, Newborn | 11 | 2022 | 1338 | 1.090 |
Why?
|
| Isoxazoles | 2 | 2017 | 81 | 1.090 |
Why?
|
| Pulmonary Circulation | 2 | 2017 | 131 | 1.080 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2016 | 249 | 0.950 |
Why?
|
| Vascular Remodeling | 2 | 2020 | 48 | 0.880 |
Why?
|
| Proton Pump Inhibitors | 2 | 2015 | 249 | 0.880 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 6942 | 0.870 |
Why?
|
| Oxidative Stress | 7 | 2018 | 1129 | 0.850 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 2 | 2020 | 280 | 0.810 |
Why?
|
| Fetus | 4 | 2018 | 601 | 0.800 |
Why?
|
| Disease Models, Animal | 7 | 2022 | 7222 | 0.760 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 2 | 2022 | 1021 | 0.740 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 2023 | 324 | 0.720 |
Why?
|
| Receptor, TIE-2 | 1 | 2020 | 82 | 0.710 |
Why?
|
| Hydrogen Peroxide | 2 | 2018 | 217 | 0.700 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2020 | 265 | 0.670 |
Why?
|
| Catalase | 1 | 2018 | 70 | 0.660 |
Why?
|
| Integrases | 1 | 2020 | 262 | 0.660 |
Why?
|
| Cytochrome P-450 CYP1A2 | 2 | 2015 | 63 | 0.650 |
Why?
|
| Cell Proliferation | 4 | 2020 | 7226 | 0.620 |
Why?
|
| Pneumonia | 3 | 2022 | 751 | 0.610 |
Why?
|
| MAP Kinase Signaling System | 2 | 2020 | 848 | 0.610 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2017 | 25 | 0.610 |
Why?
|
| Superoxide Dismutase | 1 | 2018 | 266 | 0.610 |
Why?
|
| Lung Injury | 5 | 2020 | 131 | 0.590 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2017 | 74 | 0.590 |
Why?
|
| Echocardiography, Doppler, Pulsed | 1 | 2016 | 20 | 0.570 |
Why?
|
| Heme Oxygenase-1 | 1 | 2016 | 54 | 0.570 |
Why?
|
| Infant, Newborn | 14 | 2023 | 8223 | 0.560 |
Why?
|
| Fetal Growth Retardation | 1 | 2017 | 194 | 0.550 |
Why?
|
| Neovascularization, Physiologic | 1 | 2018 | 345 | 0.550 |
Why?
|
| Microvessels | 1 | 2016 | 135 | 0.530 |
Why?
|
| Transcription Factor RelB | 1 | 2015 | 16 | 0.530 |
Why?
|
| Transcriptome | 3 | 2020 | 1859 | 0.530 |
Why?
|
| Capillaries | 1 | 2015 | 99 | 0.510 |
Why?
|
| Signal Transduction | 6 | 2020 | 11965 | 0.510 |
Why?
|
| Proteome | 1 | 2018 | 561 | 0.490 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 673 | 0.480 |
Why?
|
| Respiration, Artificial | 1 | 2017 | 577 | 0.480 |
Why?
|
| Respiratory Mucosa | 1 | 2015 | 206 | 0.480 |
Why?
|
| Animals | 20 | 2022 | 59536 | 0.470 |
Why?
|
| Infant, Premature | 6 | 2023 | 787 | 0.470 |
Why?
|
| Vasopressins | 1 | 2013 | 62 | 0.450 |
Why?
|
| Immunologic Factors | 1 | 2017 | 649 | 0.440 |
Why?
|
| Pulmonary Artery | 1 | 2016 | 499 | 0.420 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 151 | 0.420 |
Why?
|
| Antioxidants | 1 | 2015 | 507 | 0.410 |
Why?
|
| Mice | 13 | 2022 | 34495 | 0.410 |
Why?
|
| Cells, Cultured | 5 | 2018 | 5637 | 0.400 |
Why?
|
| Hypotension | 1 | 2013 | 210 | 0.400 |
Why?
|
| Heart | 1 | 2017 | 1223 | 0.390 |
Why?
|
| Up-Regulation | 1 | 2017 | 2450 | 0.370 |
Why?
|
| Biomarkers | 3 | 2020 | 5047 | 0.370 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2011 | 200 | 0.370 |
Why?
|
| Cell Survival | 4 | 2018 | 3045 | 0.330 |
Why?
|
| Liver | 3 | 2015 | 2961 | 0.330 |
Why?
|
| Oxygen | 1 | 2013 | 754 | 0.330 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 2 | 2020 | 259 | 0.320 |
Why?
|
| Smoking | 1 | 2017 | 2440 | 0.320 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2011 | 461 | 0.310 |
Why?
|
| Gestational Age | 2 | 2023 | 1069 | 0.300 |
Why?
|
| Ductus Arteriosus, Patent | 2 | 2018 | 137 | 0.270 |
Why?
|
| Inflammation | 4 | 2022 | 2522 | 0.260 |
Why?
|
| Gene Expression Regulation | 4 | 2022 | 4053 | 0.260 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2018 | 4938 | 0.260 |
Why?
|
| Organ Size | 3 | 2017 | 690 | 0.250 |
Why?
|
| Humans | 25 | 2023 | 261506 | 0.250 |
Why?
|
| Mice, Knockout | 5 | 2020 | 5710 | 0.250 |
Why?
|
| Epithelial Cells | 1 | 2011 | 1818 | 0.240 |
Why?
|
| Microbiota | 2 | 2022 | 547 | 0.240 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 5159 | 0.240 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 1879 | 0.230 |
Why?
|
| Pregnancy | 6 | 2021 | 7573 | 0.220 |
Why?
|
| Vascular Resistance | 1 | 2023 | 200 | 0.220 |
Why?
|
| Feasibility Studies | 3 | 2017 | 2292 | 0.220 |
Why?
|
| Endothelium, Vascular | 2 | 2018 | 891 | 0.220 |
Why?
|
| Random Allocation | 2 | 2015 | 703 | 0.220 |
Why?
|
| Mice, Inbred DBA | 2 | 2013 | 110 | 0.210 |
Why?
|
| Dysbiosis | 2 | 2022 | 134 | 0.200 |
Why?
|
| Mice, 129 Strain | 1 | 2021 | 170 | 0.200 |
Why?
|
| Chemokine CCL2 | 2 | 2011 | 203 | 0.190 |
Why?
|
| Receptor Activity-Modifying Protein 2 | 1 | 2020 | 15 | 0.190 |
Why?
|
| Gene Dosage | 2 | 2021 | 829 | 0.180 |
Why?
|
| Malondialdehyde | 2 | 2016 | 47 | 0.180 |
Why?
|
| Female | 13 | 2021 | 141928 | 0.170 |
Why?
|
| Ligands | 1 | 2022 | 995 | 0.170 |
Why?
|
| RNA, Small Interfering | 2 | 2015 | 2216 | 0.170 |
Why?
|
| Time Factors | 3 | 2017 | 12926 | 0.160 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 987 | 0.160 |
Why?
|
| Atmosphere Exposure Chambers | 1 | 2017 | 1 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Pulsed | 1 | 2017 | 17 | 0.160 |
Why?
|
| Neutrophil Infiltration | 3 | 2015 | 109 | 0.160 |
Why?
|
| Alprostadil | 1 | 2018 | 33 | 0.160 |
Why?
|
| Respiratory System | 1 | 2018 | 125 | 0.160 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2017 | 35 | 0.150 |
Why?
|
| Neonatal Sepsis | 1 | 2017 | 28 | 0.150 |
Why?
|
| Chorioamnionitis | 1 | 2017 | 41 | 0.150 |
Why?
|
| Perinatal Care | 1 | 2017 | 63 | 0.150 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 526 | 0.150 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2020 | 343 | 0.150 |
Why?
|
| Infant, Extremely Premature | 1 | 2017 | 75 | 0.150 |
Why?
|
| Vasodilator Agents | 1 | 2018 | 219 | 0.140 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 72 | 0.140 |
Why?
|
| Structure-Activity Relationship | 1 | 2018 | 931 | 0.140 |
Why?
|
| Cytochrome P-450 Enzyme Inducers | 1 | 2015 | 3 | 0.140 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2016 | 261 | 0.130 |
Why?
|
| Injections, Intraperitoneal | 1 | 2015 | 197 | 0.130 |
Why?
|
| Databases, Genetic | 2 | 2016 | 745 | 0.130 |
Why?
|
| Anti-Ulcer Agents | 1 | 2015 | 101 | 0.130 |
Why?
|
| Infant Care | 1 | 2005 | 48 | 0.130 |
Why?
|
| Stroke Volume | 1 | 2017 | 577 | 0.130 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 208 | 0.130 |
Why?
|
| Male | 9 | 2020 | 123000 | 0.130 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 268 | 0.120 |
Why?
|
| Benzo(a)pyrene | 1 | 2014 | 35 | 0.120 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 335 | 0.120 |
Why?
|
| Peptide Fragments | 1 | 2020 | 1271 | 0.120 |
Why?
|
| Mice, Transgenic | 1 | 2021 | 4143 | 0.120 |
Why?
|
| Lypressin | 1 | 2013 | 11 | 0.120 |
Why?
|
| Necrosis | 1 | 2015 | 580 | 0.110 |
Why?
|
| Actins | 1 | 2016 | 608 | 0.110 |
Why?
|
| Cell Death | 1 | 2015 | 671 | 0.110 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 1077 | 0.110 |
Why?
|
| Apoptosis | 2 | 2018 | 7591 | 0.110 |
Why?
|
| Cell Cycle | 1 | 2018 | 2084 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 1217 | 0.110 |
Why?
|
| Hemodynamics | 1 | 2016 | 935 | 0.100 |
Why?
|
| Echocardiography | 1 | 2017 | 1182 | 0.100 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2013 | 92 | 0.100 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2013 | 280 | 0.100 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 677 | 0.100 |
Why?
|
| Gene Deletion | 1 | 2017 | 1442 | 0.100 |
Why?
|
| Cytoprotection | 1 | 2011 | 66 | 0.100 |
Why?
|
| RNA Interference | 1 | 2016 | 1408 | 0.100 |
Why?
|
| Microsomes | 1 | 2011 | 61 | 0.100 |
Why?
|
| Molecular Targeted Therapy | 1 | 2022 | 2330 | 0.100 |
Why?
|
| Enzyme Induction | 1 | 2011 | 249 | 0.100 |
Why?
|
| Pulmonary Edema | 1 | 2011 | 80 | 0.100 |
Why?
|
| Myocardium | 1 | 2017 | 1313 | 0.100 |
Why?
|
| Transfection | 1 | 2016 | 2944 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 521 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2015 | 1038 | 0.090 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2016 | 2508 | 0.090 |
Why?
|
| Infant | 2 | 2023 | 13310 | 0.090 |
Why?
|
| Computational Biology | 1 | 2016 | 1271 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2015 | 1538 | 0.090 |
Why?
|
| Blotting, Western | 2 | 2014 | 3536 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 1498 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2013 | 778 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 2054 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 4892 | 0.080 |
Why?
|
| Incidence | 1 | 2017 | 5673 | 0.080 |
Why?
|
| RNA, Messenger | 1 | 2015 | 6150 | 0.070 |
Why?
|
| Disease Progression | 1 | 2016 | 6682 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 3639 | 0.060 |
Why?
|
| Lipid Peroxidation | 2 | 2015 | 157 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 5539 | 0.060 |
Why?
|
| Rickets | 1 | 2003 | 10 | 0.060 |
Why?
|
| Osteomalacia | 1 | 2003 | 36 | 0.060 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2017 | 7702 | 0.050 |
Why?
|
| Risk Factors | 1 | 2017 | 17523 | 0.050 |
Why?
|
| Immunohistochemistry | 1 | 2011 | 7548 | 0.050 |
Why?
|
| Metabolome | 1 | 2022 | 344 | 0.040 |
Why?
|
| Reference Standards | 1 | 2020 | 339 | 0.040 |
Why?
|
| Infant, Premature, Diseases | 1 | 2020 | 245 | 0.040 |
Why?
|
| ROC Curve | 1 | 2020 | 1183 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 14551 | 0.030 |
Why?
|
| Dinoprost | 1 | 2015 | 33 | 0.030 |
Why?
|
| Aldehydes | 1 | 2015 | 44 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 28 | 0.030 |
Why?
|
| Cytochrome P-450 CYP1B1 | 1 | 2014 | 42 | 0.030 |
Why?
|
| India | 1 | 2005 | 301 | 0.030 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 181 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2014 | 224 | 0.030 |
Why?
|
| Leukocyte Count | 1 | 2015 | 684 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2014 | 210 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 111 | 0.030 |
Why?
|
| Breast Feeding | 1 | 2005 | 239 | 0.030 |
Why?
|
| Mutation | 1 | 2013 | 15179 | 0.030 |
Why?
|
| Open Reading Frames | 1 | 2013 | 250 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2020 | 4971 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 2013 | 844 | 0.020 |
Why?
|
| Neutrophils | 1 | 2015 | 835 | 0.020 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2005 | 573 | 0.020 |
Why?
|
| Body Weight | 1 | 2014 | 1293 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2013 | 1471 | 0.020 |
Why?
|
| Adult | 1 | 2015 | 77950 | 0.020 |
Why?
|
| Length of Stay | 1 | 2005 | 1900 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 4233 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 6089 | 0.020 |
Why?
|
| Rats | 1 | 2014 | 6086 | 0.020 |
Why?
|